Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other 1

Conditions

Obesity 3Prostatic Neoplasms 2Polycystic Ovary Syndrome 2Overweight 1Neoplasms 1Metabolic Syndrome 1Inflammation 1Endometrial Neoplasms 1Endometrial Hyperplasia 1Dyslipidemias 1

Interventions

semaglutide 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1Topiramate 1Tirzepatide 1Surveys and Questionnaires 1Qsymia 1Phlebotomy 1Phentermine 1Naltrexone 1Metformin 1Magnesium 1Liraglutide 1Glucagon-Like Peptide-1 Receptor 1Diethylpropion 1Carnitine 1Bupropion 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Dyslipidemias × semaglutide × 1 year × Clear all
NCT05756764 2025-09-09

Anti-obesity Pharmacotherapy and Inflammation

Louisiana State University Health Sciences Center in New Orleans

Active not recruiting
30 enrolled
Other

Inflammation, Obesity, Metabolic Syndrome, Dyslipidemias

Data powered by HemOnc (CC BY 4.0) Colophon âš¡